iifl-logo-icon 1

Beryl Drugs Ltd Share Price

31.5
(-0.16%)
Jul 16, 2024|03:40:00 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open31.05
  • Day's High32.18
  • 52 Wk High44.98
  • Prev. Close31.55
  • Day's Low31.05
  • 52 Wk Low14.25
  • Turnover (lac)0.89
  • P/E20.76
  • Face Value10
  • Book Value17.55
  • EPS1.52
  • Mkt. Cap (Cr.)15.98
  • Div. Yield0
No Records Found

Beryl Drugs Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

31.05

Prev. Close

31.55

Turnover(Lac.)

0.89

Day's High

32.18

Day's Low

31.05

52 Week's High

44.98

52 Week's Low

14.25

Book Value

17.55

Face Value

10

Mkt Cap (₹ Cr.)

15.98

P/E

20.76

EPS

1.52

Divi. Yield

0

Beryl Drugs Ltd Corporate Action

25 Aug 2023

12:00 AM

AGM

Announcement Date: 25 Aug, 2023

arrow

22 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

25 Aug 2023

12:00 AM

BookCloser

arrow

Beryl Drugs Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Beryl Drugs Ltd SHAREHOLDING SNAPSHOT

16 Jul, 2024|01:52 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 26.38%

Foreign: 0.00%

Indian: 26.38%

Non-Promoter- 73.61%

Institutions: 0.00%

Non-Institutions: 73.61%

Custodian: 0.00%

Share Price

Beryl Drugs Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

5.09

5.09

5.09

5.09

Preference Capital

0

0

0

0

Reserves

2.97

2.2

2.84

2.53

Net Worth

8.06

7.29

7.93

7.62

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

14.07

12.81

15.14

10.93

yoy growth (%)

9.84

-15.37

38.5

-16.6

Raw materials

-7.41

-6.6

-9.27

-6.49

As % of sales

52.7

51.56

61.24

59.41

Employee costs

-1.17

-0.96

-0.77

-1

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

-0.1

0.15

1.27

-0.37

Depreciation

-1.27

-0.65

-0.32

-0.37

Tax paid

-0.1

-0.1

-0.28

-0.07

Working capital

1.26

-0.7

0.27

-0.17

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

9.84

-15.37

38.5

-16.6

Op profit growth

59.97

-13.01

-1,703.87

-112.59

EBIT growth

-24.45

-65.93

-920.72

-135.96

Net profit growth

399.81

-95.17

-322.01

-368.51

View Ratios

No Record found

Beryl Drugs Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,585.65

124.663,80,450.55867.60.855,536.9998.75

Cipla Ltd

CIPLA

1,516.05

32.961,22,423.771,038.40.563,444.92346.41

Divis Laboratories Ltd

DIVISLAB

4,575.35

77.071,21,461.175310.652,259507.93

Zydus Lifesciences Ltd

ZYDUSLIFE

1,187.9

34.771,19,530.541,405.20.253,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,792.8

26.451,13,324.081,034.80.595,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Beryl Drugs Ltd

Management

Register Office

Registrar Office

ED / MD / Promoter

Sanjay Sethi

Chairman & Non Executive Dir.

Sudhir Sethi

Independent Non Exe. Director

Abhinav Naik

Independent Non Exe. Director

Shreya Saraf

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Beryl Drugs Limited, based in Indore, was incorporated on August 24, 1993. The Company acquired the running business of M/s Flora and Fauna Remedies Limited on December 15, 1993. The Shares of Company were listed on M.P. Stock Exchange, Bombay Stock Exchange and Ahmedabad Stock Exchange.The Company thereafter has been engaged in the manufacture, sale, and export of branded, generic pharmaceutical formulations in India and internationally. It offers I.V.fluids, and a range of small and large volume injectables. It provides a range of eye/ear drops, veterinary products, and injections. It sells products through sales and distribution network. In addition, it offers research and development, as well as contract manufacturing services. Beryl Drugs Ltd. is based in Indore, India.Beryl emerged into a global network of pharmaceutical manufacturing, research and development, contract manufacturing services and veterinary products. It owns brands like BERI-CEF injection, F-Neuron, Amplicillin INJ, P-Mol, Biprox, B-Flox and many more.The manufacturing facilities of the Company are in compliance with WHO GMP specifications. The Company is in tune with the current manufacturing trends in healthcare industry. The Company is an ISO 9001:2000 certified for quality management, which acknowledges quality as the first and the foremost important aspect into the business of healthcare products.
Read More

Company FAQs

What is the Beryl Drugs Ltd share price today?

Down Arrow

The Beryl Drugs Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹31.5 today.

What is the Market Cap of Beryl Drugs Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Beryl Drugs Ltd is ₹15.98 Cr. as of 16 Jul ‘24

What is the PE and PB ratio of Beryl Drugs Ltd?

Down Arrow

The PE and PB ratios of Beryl Drugs Ltd is 20.76 and 1.80 as of 16 Jul ‘24

What is the 52 Week High and Low of Beryl Drugs Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Beryl Drugs Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Beryl Drugs Ltd is ₹14.25 and ₹44.98 as of 16 Jul ‘24

What is the CAGR of Beryl Drugs Ltd?

Down Arrow

Beryl Drugs Ltd's CAGR for 5 Years at 37.67%, 3 Years at 49.67%, 1 Year at 88.70%, 6 Month at 31.46%, 3 Month at -6.10% and 1 Month at -10.52%.

What is the shareholding pattern of Beryl Drugs Ltd?

Down Arrow

The shareholding pattern of Beryl Drugs Ltd is as follows:
Promoters - 26.38 %
Institutions - 0.00 %
Public - 73.62 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.